{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:17:36Z","timestamp":1787170656610,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["CDA 14\\u2013422"],"award-info":[{"award-number":["CDA 14\\u2013422"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["050602"],"award-info":[{"award-number":["050602"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jamda.2020.11.037","type":"journal-article","created":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T19:41:47Z","timestamp":1609184507000},"page":"1813-1818.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["To What Extent Do Local Nursing Home Prescribing Patterns Relate to Psychotropic Prescribing in Assisted Living?"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3436-2184","authenticated-orcid":false,"given":"Kali S.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Wretman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"Sloane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Carder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna S.","family":"Beeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2020.11.037_bib1","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1377\/hlthaff.2013.1255","article-title":"Dementia prevalence and care in assisted living","volume":"33","author":"Zimmerman","year":"2014","journal-title":"Health Aff (Millbank)"},{"key":"10.1016\/j.jamda.2020.11.037_bib2","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.jamda.2019.08.030","article-title":"The Minimum Data Set Agitated and Reactive Behavior Scale: measuring behaviors in nursing home residents with dementia","volume":"20","author":"McCreedy","year":"2019","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"3 Suppl 2","key":"10.1016\/j.jamda.2020.11.037_bib3","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.jamda.2006.12.012","article-title":"Difficult behaviors in long-term care patients with dementia","volume":"8","author":"Buhr","year":"2007","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2020.11.037_bib4","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/JGP.0b013e318211057d","article-title":"Prevalence of neuropsychiatric symptoms in CIND and its subtypes: The Cache County Study","volume":"20","author":"Peters","year":"2012","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2020.11.037_bib5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/gps.1858","article-title":"Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: The Cache County Study","volume":"23","author":"Steinberg","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2020.11.037_bib6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s40266-016-0414-x","article-title":"A\u00a0review of adverse outcomes associated with psychoactive drug use in nursing home residents with dementia","volume":"33","author":"Lapeyre-Mestre","year":"2016","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2020.11.037_bib7","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1001\/jama.293.20.2462","article-title":"FDA warns antipsychotic drugs may be risky for elderly","volume":"293","author":"Kuehn","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2020.11.037_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/archinternmed.2009.456","article-title":"Impact of FDA black box advisory on antipsychotic medication use","volume":"170","author":"Dorsey","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jamda.2020.11.037_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.300.4.379","article-title":"FDA: Antipsychotics risky for elderly","volume":"300","author":"Kuehn","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2020.11.037_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3122\/jabfm.2018.01.170230","article-title":"Primary care physician perspectives about antipsychotics and other medications for symptoms of dementia","volume":"31","author":"Kerns","year":"2018","journal-title":"J\u00a0Am Board Fam Med"},{"issue":"5 Suppl B","key":"10.1016\/j.jamda.2020.11.037_bib11","first-page":"S1","article-title":"Summary of the comparative effectiveness review on off-label use of atypical antipsychotics","volume":"18","author":"Maher","year":"2012","journal-title":"J\u00a0Manag Care Pharm"},{"key":"10.1016\/j.jamda.2020.11.037_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1017\/S1041610217002344","article-title":"An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia","volume":"30","author":"Dyer","year":"2018","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2020.11.037_bib13","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3233\/JAD-140579","article-title":"The efficacy and safety of atypical antipsychotics for the treatment of dementia: A meta-analysis of randomized placebo-controlled trials","volume":"42","author":"Ma","year":"2014","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2020.11.037_bib14","first-page":"CD002852","article-title":"Haloperidol for agitation in dementia","volume":"2","author":"Lonergan","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jamda.2020.11.037_bib15","first-page":"CD003476","article-title":"The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease","volume":"1","author":"Ballard","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jamda.2020.11.037_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12877-018-0752-0","article-title":"Psychotropic medications in older people in residential care facilities and associations with quality of life: A cross-sectional study","volume":"18","author":"Harrison","year":"2018","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jamda.2020.11.037_bib18","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1001\/jamainternmed.2018.0379","article-title":"Association of the Centers for Medicare & Medicaid Services' national partnership to improve dementia care with the use of antipsychotics and other psychotropics in long-term care in the United States from 2009 to 2014","volume":"178","author":"Maust","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jamda.2020.11.037_bib20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/ageing\/afr032","article-title":"Associated factors with antipsychotic use in assisted living facilities: A cross-sectional study of 4367 residents","volume":"40","author":"Larrayadieu","year":"2011","journal-title":"Age Ageing"},{"key":"10.1016\/j.jamda.2020.11.037_bib21","doi-asserted-by":"crossref","first-page":"673.e9","DOI":"10.1016\/j.jamda.2016.04.028","article-title":"Prevalence and medication management of dementia by a medical practice providing onsite care in assisted living","volume":"17","author":"Kronhaus","year":"2016","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2020.11.037_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12877-017-0428-1","article-title":"Variation in use of antipsychotic medications in nursing homes in the United States: A systematic review","volume":"17","author":"Cioltan","year":"2017","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jamda.2020.11.037_bib23","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jama.2012.211266","article-title":"Antipsychotic use among nursing home residents","volume":"309","author":"Briesacher","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2020.11.037_bib24","first-page":"S195","article-title":"How good is assisted living? Findings and implications from an outcomes study","volume":"60","author":"Zimmerman","year":"2005","journal-title":"J\u00a0Gerontol B Psychol Sci Soc Sci"},{"key":"10.1016\/j.jamda.2020.11.037_bib25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jamda.2014.01.010","article-title":"Clinical, demographic, and pharmacologic features of nursing home residents with Huntington's disease","volume":"15","author":"Zarowitz","year":"2014","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2020.11.037_bib26","author":"Zeigermann"},{"key":"10.1016\/j.jamda.2020.11.037_bib27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1179\/sre.1975.23.176.88","article-title":"Direct and inverse solutions of geodesics on the ellipsoid with application of nested equations","volume":"23","author":"Vincenty","year":"1975","journal-title":"Survey Review"},{"key":"10.1016\/j.jamda.2020.11.037_bib28","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/jgs.16410","article-title":"State variability in the prevalence and healthcare utilization of assisted living residents with dementia","volume":"68","author":"Thomas","year":"2020","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2020.11.037_bib30","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1056\/NEJMp1010220","article-title":"Geographic variation in the quality of prescribing","volume":"363","author":"Zhang","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2020.11.037_bib31","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/archinternmed.2012.3717","article-title":"Geographic variation in outpatient antibiotic prescribing among older adults","volume":"172","author":"Zhang","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jamda.2020.11.037_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.amjopharm.2009.05.001","article-title":"Results of a longitudinal analysis of national data to examine relationships between organizational and market characteristics and changes in antipsychotic prescribing in US nursing homes from 1996 through 2006","volume":"7","author":"Castle","year":"2009","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.jamda.2020.11.037_bib33","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/00005650-200012000-00003","article-title":"Influence of facility characteristics on use of antipsychotic medications in nursing homes","volume":"38","author":"Hughes","year":"2000","journal-title":"Med Care"},{"key":"10.1016\/j.jamda.2020.11.037_bib34","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/JGP.0b013e3181d6c0c6","article-title":"Antipsychotic and benzodiazepine use among nursing home residents: Findings from the 2004 National Nursing Home Survey","volume":"18","author":"Stevenson","year":"2010","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2020.11.037_bib35","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/gps.4098","article-title":"Antipsychotic medication use in nursing homes: A proposed measure of quality","volume":"29","author":"Lucas","year":"2014","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2020.11.037_bib36","first-page":"CD008634","article-title":"Psychosocial interventions for reducing antipsychotic medication in care home residents","volume":"12","author":"Richter","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jamda.2020.11.037_bib38","first-page":"S195","article-title":"How good is assisted living? Findings and implications from an outcomes study","volume":"60","author":"Zimmerman","year":"2005","journal-title":"J\u00a0Gerontol B Psychol Sci Soc Sci"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861020310239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861020310239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:09:26Z","timestamp":1778616566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861020310239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1525861020310239"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2020.11.037","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"To What Extent Do Local Nursing Home Prescribing Patterns Relate to Psychotropic Prescribing in Assisted Living?","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2020.11.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}